2018 Q1 Form 10-Q Financial Statement

#000070084118000014 Filed on May 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q2
Revenue $50.81M $46.34M
YoY Change -1.77%
Cost Of Revenue $38.26M $34.59M
YoY Change 0.26%
Gross Profit $12.56M $11.75M
YoY Change -7.29%
Gross Profit Margin 24.71% 25.36%
Selling, General & Admin $10.42M $10.32M
YoY Change -1.41%
% of Gross Profit 83.0% 87.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $414.0K $397.0K
YoY Change 1.79%
% of Gross Profit 3.3% 3.38%
Operating Expenses $10.84M $10.32M
YoY Change -1.41%
Operating Profit $1.720M $1.038M
YoY Change -43.0%
Interest Expense -$310.0K -$140.0K
YoY Change -30.0%
% of Operating Profit -18.02% -13.49%
Other Income/Expense, Net -$307.0K -$136.0K
YoY Change -32.0%
Pretax Income $1.413M $902.0K
YoY Change -44.36%
Income Tax $362.0K $352.0K
% Of Pretax Income 25.62% 39.02%
Net Earnings $1.051M $550.0K
YoY Change -45.05%
Net Earnings / Revenue 2.07% 1.19%
Basic Earnings Per Share
Diluted Earnings Per Share $0.09 $45.64K
COMMON SHARES
Basic Shares Outstanding 12.24M 11.95M
Diluted Shares Outstanding 12.26M 12.05M

Balance Sheet

Concept 2018 Q1 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $300.0K
YoY Change 200.0%
Cash & Equivalents $452.0K $293.0K
Short-Term Investments
Other Short-Term Assets $3.700M $3.300M
YoY Change -5.71%
Inventory
Prepaid Expenses
Receivables $51.91M $44.34M
Other Receivables $1.089M $1.362M
Total Short-Term Assets $57.12M $49.35M
YoY Change -16.65%
LONG-TERM ASSETS
Property, Plant & Equipment $3.337M $3.763M
YoY Change -20.36%
Goodwill $11.69M $12.33M
YoY Change 5.98%
Intangibles $87.00K $105.0K
YoY Change -54.15%
Long-Term Investments
YoY Change
Other Assets $2.300M $200.0K
YoY Change -60.0%
Total Long-Term Assets $14.10M $12.69M
YoY Change 3.05%
TOTAL ASSETS
Total Short-Term Assets $57.12M $49.35M
Total Long-Term Assets $14.10M $12.69M
Total Assets $74.55M $65.80M
YoY Change -13.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.900M $11.60M
YoY Change -16.55%
Accrued Expenses $7.700M $7.200M
YoY Change 5.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.44M $20.59M
YoY Change -5.65%
LONG-TERM LIABILITIES
Long-Term Debt $32.00M $12.70M
YoY Change -36.18%
Other Long-Term Liabilities $1.400M $200.0K
YoY Change -80.0%
Total Long-Term Liabilities $33.40M $12.90M
YoY Change -38.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.44M $20.59M
Total Long-Term Liabilities $33.40M $12.90M
Total Liabilities $51.23M $33.96M
YoY Change -20.94%
SHAREHOLDERS EQUITY
Retained Earnings -$64.83M -$67.34M
YoY Change -1.9%
Common Stock $753.0K $738.0K
YoY Change 1.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.99M $14.99M
YoY Change 36.71%
Treasury Stock Shares $2.823M $2.823M
Shareholders Equity $23.32M $31.84M
YoY Change
Total Liabilities & Shareholders Equity $74.55M $65.80M
YoY Change -13.7%

Cashflow Statement

Concept 2018 Q1 2017 Q2
OPERATING ACTIVITIES
Net Income $1.051M $550.0K
YoY Change -45.05%
Depreciation, Depletion And Amortization $414.0K $397.0K
YoY Change 1.79%
Cash From Operating Activities -$7.044M $1.869M
YoY Change 77.32%
INVESTING ACTIVITIES
Capital Expenditures $289.0K $92.00K
YoY Change -76.65%
Acquisitions
YoY Change
Other Investing Activities -$10.00K $0.00
YoY Change
Cash From Investing Activities -$300.0K -$92.00K
YoY Change -76.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $365.0K
YoY Change -38.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.928M -1.767M
YoY Change 14.37%
NET CHANGE
Cash From Operating Activities -7.044M 1.869M
Cash From Investing Activities -300.0K -92.00K
Cash From Financing Activities 4.928M -1.767M
Net Change In Cash -2.416M 10.00K
YoY Change -101.13%
FREE CASH FLOW
Cash From Operating Activities -$7.044M $1.869M
Capital Expenditures $289.0K $92.00K
Free Cash Flow -$7.333M $1.777M
YoY Change 169.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 rcmt Annual Depreciation Rate
AnnualDepreciationRate
0.2
CY2018Q1 rcmt Business Combinations Acquisitions With Contingent Consideration Outstanding
BusinessCombinationsAcquisitionsWithContingentConsiderationOutstanding
6
CY2018Q1 rcmt Estimated Future Contingent Consideration Payments
EstimatedFutureContingentConsiderationPayments
2091000
CY2018Q1 rcmt Estimated Future Contingent Consideration Payments Current
EstimatedFutureContingentConsiderationPaymentsCurrent
741000
CY2018Q1 rcmt Estimated Future Contingent Consideration Payments Year Three
EstimatedFutureContingentConsiderationPaymentsYearThree
725000
CY2018Q1 rcmt Estimated Future Contingent Consideration Payments Year Two
EstimatedFutureContingentConsiderationPaymentsYearTwo
625000
CY2018Q1 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
332232
CY2017Q4 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
332232
CY2018Q1 rcmt Liabilities Net
LiabilitiesNet
400000
CY2017Q4 rcmt Liabilities Net
LiabilitiesNet
1700000
CY2018Q1 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
681000
CY2017Q2 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
355000
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7404000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8634000
CY2018Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1503000
CY2017Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
4661000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51913000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46080000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4281000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4563000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2465000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2395000
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104844000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104540000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
112000
CY2018Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-8095000
CY2017Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1319000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
112000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
203000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1116000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
967000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40000
CY2018Q1 us-gaap Assets
Assets
74552000
CY2017Q2 us-gaap Assets
Assets
65800000
CY2017Q4 us-gaap Assets
Assets
73279000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
57116000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
55639000
CY2018Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
14099000
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
14194000
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
4100000
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
741000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
741000
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1350000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1350000
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
289000
CY2017Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
92000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2851000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
279000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
452000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
293000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2399000
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14000
CY2018Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
951138
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
996546
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15062930
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15017522
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12239758
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12194350
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
753000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
751000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
981000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
554000
CY2018Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
295000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38257000
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34589000
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
2101000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
2189000
CY2018Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
226000
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
215000
CY2018Q1 us-gaap Depreciation
Depreciation
396000
CY2017Q2 us-gaap Depreciation
Depreciation
380000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
414000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
397000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
414000
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
397000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.09
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
17000
CY2017Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4000
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7696000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7780000
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
376000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-41000
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000
CY2018Q1 us-gaap Goodwill
Goodwill
11685000
CY2017Q4 us-gaap Goodwill
Goodwill
11685000
CY2018Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2018Q1 us-gaap Gross Profit
GrossProfit
12555000
CY2017Q2 us-gaap Gross Profit
GrossProfit
11752000
CY2018Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2017Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1413000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
902000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
362000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
352000
CY2017 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1000000
CY2017 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
200000
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
304000
CY2017Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
98000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1212000
CY2017Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-607000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6078000
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-663000
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-269000
CY2018Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-11000
CY2017Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
157000
CY2018Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-91000
CY2017Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-98000
CY2017Q2 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-70000
CY2017Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
51000
CY2018Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1243000
CY2017Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-217000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2000
CY2017Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21000
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
18747
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
101114
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
87000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
105000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
105000
CY2018Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-266000
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-138000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
167000
CY2017Q2 us-gaap Interest Paid Net
InterestPaidNet
113000
CY2018Q1 us-gaap Liabilities
Liabilities
51234000
CY2017Q4 us-gaap Liabilities
Liabilities
51248000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74552000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73279000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17442000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22188000
CY2018Q1 us-gaap Litigation Reserve
LitigationReserve
100000
CY2018Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
32014000
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
27279000
CY2018Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
10000000
CY2018Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Contingencies</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business.&nbsp; As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.&nbsp; The Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be covered by insurance as it pertains to some or all of these matters. A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.&nbsp; Once established, a provision <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>change in the future due to new developments or changes in circumstances, and could increase or decrease the Company&#x2019;s earnings in the period that the changes are made.&nbsp; Asserted claims in these matters sought approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10.0</div> million in damages (including <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.3</div> million in counter claims described below) as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018, </div>the Company had an accrual of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million for any such liabilities.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">The Company has a dispute with a customer that is a major utility in the United States. Essentially, the customer has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> paid the balance of accounts receivable the Company believes are owed to the Company. The Company recently compelled arbitration with this customer. &nbsp;As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018 </div>the total amount due from this customer is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.9</div> million, subject to an upward adjustment following disclosures by the customer in the arbitration.&nbsp; Additionally, as part of the arbitration process, the customer has asserted counter claims of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.3</div> million.&nbsp; The Company also believes these counter claims were retaliatory in nature.&nbsp; Prior to the arbitration, the customer had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> asserted any claims.&nbsp; The Company believes these asserted claims have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> merit and were merely asserted as a strategy to reduce the Company&#x2019;s claims in any arbitration award or potential settlement agreement. The Company believes that its accounts receivable balance, subject to reserves, is collectible. Furthermore, the Company believes that this arbitration will conclude sometime late in fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> or early fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div>&nbsp; While the Company believes the customer&#x2019;s counter claims to be frivolous and without merit, it can give <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurances that it will ultimately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have to pay all or a portion of such claims.&nbsp; The Company is continuing work on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the engagements that have given rise to this dispute and also on several engagements from the same client that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently part of the arbitration.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be covered by insurance.</div></div>
CY2018Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
9300000
CY2018Q1 us-gaap Loss Contingency Receivable
LossContingencyReceivable
5900000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4928000
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1767000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-300000
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7044000
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1869000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1051000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
550000
CY2018Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10835000
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10714000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1720000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1038000
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-70000
CY2017Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-307000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-136000
CY2018Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1089000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3002000
CY2018Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
CY2017Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
8000
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2017Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
365000
CY2018Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
CY2017Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
8000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
289000
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3662000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3706000
CY2018Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
23716000
CY2017Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
22058000
CY2018Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
194000
CY2017Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
192000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7618000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8009000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3337000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3446000
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
162000
CY2017Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
161000
CY2018Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
18982000
CY2017Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
23644000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64827000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65878000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
50812000
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46341000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10421000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10317000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
112000
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
203000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
131872
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
177280
CY2018Q1 us-gaap Share Price
SharePrice
5.77
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
194000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
23318000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
22031000
CY2017 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1200000
CY2018Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
98000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
372000
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2823172
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2823172
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
14987000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14987000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12257507
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12047767
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12238760
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11946653

Files In Submission

Name View Source Status
0000700841-18-000014-index-headers.html Edgar Link pending
0000700841-18-000014-index.html Edgar Link pending
0000700841-18-000014.txt Edgar Link pending
0000700841-18-000014-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q033118.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rcmt-20180331.xml Edgar Link completed
rcmt-20180331.xsd Edgar Link pending
rcmt-20180331_cal.xml Edgar Link unprocessable
rcmt-20180331_def.xml Edgar Link unprocessable
rcmt-20180331_lab.xml Edgar Link unprocessable
rcmt-20180331_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending